These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3549269)

  • 1. [The risk in using growth hormone obtained from human pituitary glands].
    Romer T
    Endokrynol Pol; 1986; 37(4):189-91. PubMed ID: 3549269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is there a causative relation between infectious degenerative encephalopathy and the use of growth hormone?].
    Romer TE
    Pediatr Pol; 1986 Nov; 61(11):740-4. PubMed ID: 3295737
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of pituitary growth hormone.
    Adlard P; Preece MA
    Lancet; 1994 Aug; 344(8922):612-3. PubMed ID: 7914978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Iatrogenic Creutzfeld-Jakob disease induced by the administration of extracted growth hormone].
    Rev Neurol (Paris); 1993; 149(10):515-6. PubMed ID: 8023062
    [No Abstract]   [Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease with reference to the safety of pituitary growth hormone.
    Bannister BA; McCormick A
    J Infect; 1987 Jan; 14(1):7-12. PubMed ID: 3546511
    [No Abstract]   [Full Text] [Related]  

  • 6. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
    Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
    Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human growth hormone treatment and Creutzfeldt-Jakob disease.
    Sartorio A; Arosio M; Faglia G; Resentini M; Morabito F
    J Endocrinol Invest; 1986 Oct; 9(5):439. PubMed ID: 3540083
    [No Abstract]   [Full Text] [Related]  

  • 8. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts.
    Brown P
    Pediatrics; 1988 Jan; 81(1):85-92. PubMed ID: 3275936
    [No Abstract]   [Full Text] [Related]  

  • 11. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.
    Brown P
    Neurology; 1988 Jul; 38(7):1135-7. PubMed ID: 3290705
    [No Abstract]   [Full Text] [Related]  

  • 12. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical review 58: Creutzfeldt-Jakob disease in recipients of pituitary hormones.
    Frasier SD; Foley TP
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1277-9. PubMed ID: 8200924
    [No Abstract]   [Full Text] [Related]  

  • 14. The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment.
    Hintz RL
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2298-301. PubMed ID: 7629222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Iatrogenic Creutzfeld-Jakob disease. Significance of cases observed after extracted growth hormone treatment].
    Billette de Villemeur T
    Rev Neurol (Paris); 1998 Oct; 154(10):651-2. PubMed ID: 9846334
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E
    Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].
    Rikken B; Massa GG; Wit JM; van den Brande JL
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348
    [No Abstract]   [Full Text] [Related]  

  • 18. [Slow-virus encephalitis in subjects treated with growth hormone extract: unexpected risks of substitute therapy].
    Butturini L
    G Clin Med; 1986 Feb; 67(1):53. PubMed ID: 3539686
    [No Abstract]   [Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
    Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
    Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.
    New MI; Brown P; Temeck JW; Owens C; Hedley-Whyte ET; Richardson EP
    Neurology; 1988 Jul; 38(7):1133-4. PubMed ID: 3290704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.